Delivery of mitoxantrone using a plant virus-based nanoparticle for the treatment of glioblastomas.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of materials chemistry. B

• Publication date

  2018-09-26

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1039/C8TB01191EPMID 30923616PMCID PMC6433411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Current Challenges and Opportunities in Treating Glioblastoma

  2018cited by this paper
• Plant viral nanoparticles-based HER2 vaccine: Immune response influenced by differential transport, localization and cellular interactions of particulate carriers.

  2017cited by this paper
• Design of virus-based nanomaterials for medicine, biotechnology, and energy.

  2016cited by this paper
• Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas

  2016cited by this paper
• High Expression of Vimentin is Associated With Progression and a Poor Outcome in Glioblastoma

  2016cited by this paper
• Identification of Mitoxantrone as a TRAIL-sensitizing agent for Glioblastoma Multiforme

  2016cited by this paper
• Utilizing Viral Nanoparticle/Dendron Hybrid Conjugates in Photodynamic Therapy for Dual Delivery to Macrophages and Cancer Cells.

  2016cited by this paper
• Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.

  2016cited by this paper
• Anti-atherogenic effect of trivalent chromium-loaded CPMV nanoparticles in human aortic smooth muscle cells under hyperglycemic conditions in vitro.

  2016cited by this paper
• Temozolomide resistance in glioblastoma multiforme

  2016cited by this paper
• Tropism of CPMV to Professional Antigen Presenting Cells Enables a Platform to Eliminate Chronic Infections.

  2015cited by this paper
• In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

  2015cited by this paper
• The ImageJ ecosystem: An open platform for biomedical image analysis

  2015cited by this paper
• CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012

  2015cited by this paper
• Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.

  2015cited by this paper
• Interface of Physics and Biology: Engineering Virus-Based Nanoparticles for Biophotonics

  2014cited by this paper
• Sensitizing cancer cells to TRAIL-induced death by micellar delivery of mitoxantrone.

  2014cited by this paper
• Endocytic uptake pathways utilized by CPMV nanoparticles.

  2013cited by this paper
• CPMV-DOX delivers.

  2013cited by this paper
• Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery.

  2013cited by this paper
• Fiji: an open-source platform for biological-image analysis

  2012cited by this paper
• Development of viral nanoparticles for efficient intracellular delivery.

  2012cited by this paper
• CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

  2012cited by this paper
• Interior engineering of a viral nanoparticle and its tumor homing properties.

  2012cited by this paper
• NIH Image to ImageJ: 25 years of image analysis

  2012cited by this paper
• Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles

  2010cited by this paper
• Interaction of Cowpea Mosaic Virus (CPMV) Nanoparticles with Antigen Presenting Cells In Vitro and In Vivo

  2009cited by this paper
• Efficient generation of cowpea mosaic virus empty virus-like particles by the proteolytic processing of precursors in insect cells and plants.

  2009cited by this paper
• Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin

  2009cited by this paper
• Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.

  2009cited by this paper
• Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment

  2008cited by this paper
• Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo.

  2007cited by this paper
• Interaction between a 54-Kilodalton Mammalian Cell Surface Protein and Cowpea Mosaic Virus

  2006cited by this paper
• Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions

  2006cited by this paper
• Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma

  2005cited by this paper
• TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation

  2005cited by this paper
• A new probe using hybrid virus-dye nanoparticles for near-infrared fluorescence tomography

  2005cited by this paper
• Intralesional Mitoxantrone Biopolymer-Mediated Chemotherapy Prolongs Survival in Rats with Experimental Brain Tumors

  2004cited by this paper
• New addresses on an addressable virus nanoblock; uniquely reactive Lys residues on cowpea mosaic virus.

  2004cited by this paper
• Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats.

  2002cited by this paper
• Locally delivered chemotherapy and repeated surgery can improve survival in glioblastoma patients

  1999cited by this paper
• Comovirus isolation and RNA extraction.

  1998cited by this paper
• Mitoxantrone-induced DNA strand breaks in cell-cultures of malignant human astrocytoma and glioblastoma tumors

  1997cited by this paper
• Interstitial chemotherapy with mitoxantrone in recurrent malignant glioma: preliminary data

  1996cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856).

  1992cited by this paper
• Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer.

  1991cited by this paper
• Characterization of the fluorescence of the antitumor agent, mitoxantrone.

  1988cited by this paper

• CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways

  2025cites this paper
• Exploratory Study on Nanoparticle Co-Delivery of Temozolomide and Ligustilide for Enhanced Brain Tumor Therapy

  2025cites this paper
• Biogenic nanoparticles: Understanding their potential role in cancer theranostics

  2025cites this paper
• Plant-Derived Immunomodulatory Nanoadjuvants for Cancer Vaccines: Current Status and Future Opportunities

  2025cites this paper
• Multi-omics and single-cell approaches reveal molecular subtypes and key cell interactions in hepatocellular carcinoma

  2025cites this paper
• Folic acid-conjugated magnetic carbon nanotube nanocarriers for targeted delivery of mitoxantrone

  2025cites this paper
• A Multifunctionalized Potyvirus-Derived Nanoparticle That Targets and Internalizes into Cancer Cells

  2024cites this paper
• Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals

  2024cites this paper
• Current Advances in Viral Nanoparticles for Biomedicine.

  2024cites this paper
• Survival rate of patient with glioblastoma: a population-based study

  2024influential citation
• Viral nanoparticles: Current advances in design and development.

  2023cites this paper
• Dynamic and Assembly Characteristics of Deep-Cavity Basket Acting as a Host for Inclusion Complexation of Mitoxantrone in Biotic and Abiotic Systems.

  2023cites this paper
• Integrative analysis of multi-omics data reveals a pseudouridine-related lncRNA signature for prediction of glioma prognosis and chemoradiotherapy sensitivity

  2023cites this paper
• Current approaches in enhancing TRAIL therapies in glioblastoma

  2023cites this paper
• Plant-derived nanoparticles and plant virus nanoparticles: Bioactivity, health management, and delivery potential

  2023cites this paper
• Plant Virus Nanoparticles Combat Cancer

  2023cites this paper
• OVERVIEW OF MITOXANTRONE-A POTENTIAL CANDIDATE FOR TREATMENT OF BREAST CANCER

  2022cites this paper
• Multifunctional plant virus nanoparticles: An emerging strategy for therapy of cancer.

  2022cites this paper
• Novel Nano-Drug Delivery System for Brain Tumor Treatment

  2022cites this paper
• Smart Nanoformulations for Brain Cancer Theranostics: Challenges and Promises

  2022cites this paper
• Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth.

  2022cites this paper
• An Up-to-Date Review of Natural Nanoparticles for Cancer Management

  2021cites this paper
• Self-assembled Viral Nanoparticles as Targeted Anticancer Vehicles

  2021cites this paper
• The pharmacology of plant virus nanoparticles.

  2021cites this paper
• Recombinant turnip yellow mosaic virus coat protein as a potential nanocarrier

  2021cites this paper
• Lignin, lipid, protein, hyaluronic acid, starch, cellulose, gum, pectin, alginate and chitosan-based nanomaterials for cancer nanotherapy: Challenges and opportunities.

  2021cites this paper
• Delivery of cancer therapies by synthetic and bio-inspired nanovectors

  2021cites this paper
• Recent progress in targeted delivery vectors based on biomimetic nanoparticles

  2021cites this paper
• Boron phenyl alanine targeted ionic liquid decorated chitosan nanoparticles for mitoxantrone delivery to glioma cell line

  2021cites this paper
• ERK-Peptide-Inhibitor-Modified Ferritin Enhanced the Therapeutic Effects of Paclitaxel in Cancer Cells and Spheroids.

  2021cites this paper
• Frontiers in Bioengineering and Biotechnology: Plant Nanoparticles for Anti-Cancer Therapy

  2021cites this paper
• Plant Virus Nanoparticles for Anti-cancer Therapy

  2021cites this paper
• Novel therapeutics for brain tumors: current practice and future prospects

  2020cites this paper
• Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?

  2020influential citation
• Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

  2020influential citation
• Virus‐Like Particles as Theranostic Platforms

  2020cites this paper
• Plant viral nanoparticles for packaging and in vivo delivery of bioactive cargos.

  2020cites this paper
• Immunological aspects of intratumoral chemotherapy and immunotherapy in malignant brain tumors

  2020cites this paper
• Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients.

  2020cites this paper
• TRAIL in oncology: From recombinant TRAIL to nano- and self-targeted TRAIL-based therapies.

  2020cites this paper
• Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging

  2019cites this paper
• Virus-derived materials: bury the hatchet with old foes.

  2019cites this paper
• Development of improved dual-diazonium reagents for faster crosslinking of tobacco mosaic virus to form hydrogels

  2019cites this paper
• Smart Nanotechnologies to Target Tumor with Deep Penetration Depth for Efficient Cancer Treatment and Imaging

  2019cites this paper